M4MM
Cresco Labs Reports Q2 2025 Financial Results
CHICAGO – Cresco Labs Inc. released its Q2 2025 financial results, revealing a mix of operational stability, revenue headwinds, and a pivotal debt restructuring. The company reported revenues of $164 million, down 11% from $184 ...
The Cannabist Co Holdings Reports Q2 2025 Financial and Operational Results
CHELMSFORD – The Cannabist Company Holdings Inc., a leading U.S. Cannabis cultivator, manufacturer, and retailer, released its financial and operational results for the second quarter of 2025, indicating ongoing efforts to streamline operations and strengthen ...
MariMed Reports Q2 2025 Financial Results
NORWOOD – MariMed Inc. released its financial results for Q2 2025 ended June 30, reflecting a blend of operational growth and financial challenges. The company reported revenue of $39.6 million, a slight decline from $40.4 ...
Israel’s Health Ministry Approves Expansion of Apex Labs’ Phase 2b Psilocybin Trial for PTSD
LOS ANGELES- Apex Labs Ltd. has secured approval from Israel’s Ministry of Health (MoH) and relevant ethics boards to expand its ongoing Phase 2b SUMMIT‑90 clinical trial assessing macrodose psilocybin therapy (APEX‑90) for post-traumatic stress disorder ...
Ohio’s Cannabis Revenue Trends Offer Strategic Guide for Pennsylvania
LOS ANGELES- As Pennsylvania moves closer to legalizing adult-use cannabis, Ohio’s first-year revenue data and regulatory experiences offer critical insights. Since launching sales in August 2024, Ohio has generated approximately $540 million in cannabis revenue ...
Rose Hill Apothecary Completes First Research-Grade Psilocybin Export to Brazil
LOS ANGELES- Rose Hill Apothecary, the research-grade psilocybin arm of Rose Hill Life Sciences, has executed its inaugural international export deal, shipping 18 kilograms of dried psilocybin-containing mushrooms to Biocase Brasil Importação e Comércio de ...
Emerging Programs Aim to Democratize Cannabis Cultivation
LOS ANGELES- Governments, industry groups, and educational institutions are launching a wave of initiatives aimed at lowering barriers to entry in cannabis cultivation and production—efforts collectively referred to as “democratizing cannabis production.” These programs focus ...
Cresco Labs Reports Q2 2025 Financial Results
CHICAGO – Cresco Labs Inc. released its Q2 2025 financial results, revealing a mix of operational stability, revenue headwinds, and a pivotal debt restructuring. The company reported revenues of $164 million, down 11% from $184 ...
The Cannabist Co Holdings Reports Q2 2025 Financial and Operational Results
CHELMSFORD – The Cannabist Company Holdings Inc., a leading U.S. Cannabis cultivator, manufacturer, and retailer, released its financial and operational results for the second quarter of 2025, indicating ongoing efforts to streamline operations and strengthen ...
MariMed Reports Q2 2025 Financial Results
NORWOOD – MariMed Inc. released its financial results for Q2 2025 ended June 30, reflecting a blend of operational growth and financial challenges. The company reported revenue of $39.6 million, a slight decline from $40.4 ...
Clearmind Medicine Announces Promising Results in Obesity Treatment from Pre-Clinical Trial
Clearmind Medicine Inc. a biotech company at the forefront of developing novel psychedelic-derived therapeutics, has announced encouraging outcomes from its latest pre-clinical trial. The study, spearheaded by Professor Joseph Tam of The Hebrew University of ...
Cybin Inc. Unveils Promising Phase 2 Results for Psychedelic Depression Treatment CYB003
Cybin Inc. a psychedelic biotech drug development, has recently announced the comprehensive results from its Phase 2 trial of CYB003, a groundbreaking treatment for Major Depressive Disorder (MDD). These findings, presented at a high-profile R&D ...
Venture West Secures $17.5 Million Refinance Loan for Cannabis Firm Cal Grow’s Headquarters
LOS ANGELES- In a significant move underscoring the growing financial robustness of the cannabis industry, Venture West Funding, a California commercial mortgage broker, has successfully arranged a $17.5 million refinance loan for Cal Grow, a ...
Oregon’s Cannabis Market Faces Oversupply Challenges Amid Regulatory Complexities
LOS ANGELES- Oregon, a state known for its progressive stance on cannabis, is currently grappling with significant oversupply issues in its market. This challenge is compounded by various other difficulties that have been persisting in ...
University of Utah Launches Medical Cannabis Research Center
LOS ANGELES- The University of Utah is taking a significant step forward in the realm of medical cannabis research with the establishment of the Center for Medical Cannabis Research (CMCR). Announced on November 21, this ...
Numinus Wellness Inc. Announces Fourth Quarter and Full Year Fiscal 2023 Results
LOS ANGELES- Numinus Wellness Inc. has announced its financial results for the fourth quarter and the full year of fiscal 2023, highlighting significant revenue growth and strategic advancements in its operations. Fourth Quarter Fiscal 2023 ...
New York Cannabis Control Board Approves Settlement
NEW YORK- In a pivotal decision this week, the New York Cannabis Control Board resolved a lawsuit brought by military veterans, unlocking the way for over 400 adult-use cannabis dispensaries to progress in the state. ...
California and Michigan Boost Social Equity in Cannabis Industry with New Funding Initiatives
LOS ANGELES- In a significant move to bolster social equity within the cannabis industry, both California and Michigan have recently taken steps to channel more funding into social equity cannabis companies. California is set to ...
Clearmind Medicine Inc Reports Promising Results in Pre-Clinical Trial for Combination Therapy
LOS ANGELES- Clearmind Medicine Inc has announced the results of its pre-clinical trial involving a combination therapy, marking a significant step in the development of treatments for addictions, obesity, metabolic disorders, and depression. The trial ...
RIV Capital’s Ambitious Transition to Adult-Use Cannabis Sales in New York
LOS ANGELES- RIV Capital, a Toronto-based cannabis investment firm, has navigated a turbulent path in its growth story, particularly in the New York market. Initially setting up as one of the few medical cannabis operators ...
Health Canada Approves Jazz Pharmaceuticals’ Epidiolex
NEW YORK- Canada's federal health regulator, Health Canada, has recently approved Epidiolex, a cannabinoid-based medicine developed by Jazz Pharmaceuticals Canada. This approval positions Epidiolex as a supplementary therapy for certain rare and severe forms of ...
Record Sales on Green Wednesday Signal Booming Cannabis Market
LOS ANGELES- The cannabis industry experienced a significant surge in sales on Green Wednesday, the day before Thanksgiving, marking it as a high-point in annual cannabis commerce. Jane Technologies reported recreational cannabis sales totaling an ...
Arkansas and Rhode Island Cannabis Markets
LOS ANGELES- October 2023 witnessed a modest reduction in medical cannabis sales in Arkansas, reaching $22.5 million, a slight decrease from the same period in 2022. This data, sourced from the state's Department of Finance ...
Wisconsin Legislators Advocate for Veterans’ Access to Psilocybin Therapy Amid National Psychedelic Research Surge
LOS ANGELES- In a groundbreaking move, Wisconsin lawmakers are pushing for enhanced access to psilocybin, a psychedelic compound found in magic mushrooms, for military veterans suffering from post-traumatic stress disorder (PTSD). This bipartisan bill represents ...
Irwin Naturals Inc. Reports Financial Performance in Q3 2023
LOS ANGELES- Irwin Naturals Inc, a key player in the cannabis and mental health sectors, recently disclosed its financial results for the third quarter of fiscal 2023, ending September 30, 2023. The report presents a complex ...
